Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;33(2):226-230.
doi: 10.1038/s41431-024-01640-9. Epub 2024 May 29.

Beyond severity: utility as a criterion for setting the scope of RGCS

Affiliations

Beyond severity: utility as a criterion for setting the scope of RGCS

Lisa Dive et al. Eur J Hum Genet. 2025 Mar.

Abstract

Reproductive genetic carrier screening (RGCS) allows prospective parents to identify and act upon their chances of having a child with a genetic condition. In deciding which genetic conditions to include in RGCS, severity is often used as a criterion. However, the concept is inherently complex, subjective and multidimensional, and determinations of severity will remain intractably contested. We propose the concept of utility as a criterion for setting the scope of RGCS, and put forward two central arguments for doing so. First, utility is a more appropriate and effective concept as it responds to context and makes an explicit connection between the purpose of RGCS and the value of information obtained for that purpose: namely, to facilitate reproductive decision-making. Utility comprises both clinical and personal utility, and varies according to the availability and accessibility of reproductive options, including pre-implantation genetic testing, prenatal genetic diagnosis, and termination of pregnancy. Second, there are ethical reasons for preferring utility over severity. Utility is a property of the information gleaned from RGCS, while severity is a property of a genetic condition or of an instance of this condition in a person. While consideration of the severity of genetic conditions is not lost when focusing on utility, the need to rely on value judgements regarding the quality of life of people who live with genetic conditions is circumvented. Therefore, utility should replace severity as justification for the inclusion of genetic conditions in RGCS programmes.

PubMed Disclaimer

Conflict of interest statement

Competing interests: EB serves as Chair of the National Indications Committee for Pre-Implantation Genetic Testing of the Netherlands. The other authors declare that they have no competing interests.

References

    1. Edwards JG, Feldman G, Goldberg J, Gregg AR, Norton ME, Rose NC, et al. Expanded carrier screening in reproductive medicine—points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine. Obstet Gynecol. 2015;125:653–62. - PubMed
    1. Gregg AR, Aarabi M, Klugman S, Leach NT, Bashford MT, Goldwaser T, et al. Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23:1793–806. - PMC - PubMed
    1. The American College of Obstetricians and Gynecologists. Carrier screening in the age of genomic medicine. Committee Opinion No. 690. Obstet Gynecol. 2017;129:35–40.
    1. The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Genetic carrier screening. 2019; C-Obs 63. https://ranzcog.edu.au/wp-content/uploads/2022/05/Genetic-carrier-screen...
    1. Goldberg JD, Pierson S, Johansen Taber K. Expanded carrier screening: what conditions should we screen for? Prenat Diagn. 2023;43:496–505. - PubMed

MeSH terms

LinkOut - more resources